v3.24.3
Statement of Cash Flows (Tables)
9 Months Ended
Sep. 30, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:
September 30,
(In millions)
2024
2023
Cash and cash equivalents$2,011.8 $2,152.3 
Restricted cash included in Other noncurrent assets
— 7.9 
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows
$2,011.8 $2,160.2 
Restrictions on Cash and Cash Equivalents
The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:
September 30,
(In millions)
2024
2023
Cash and cash equivalents$2,011.8 $2,152.3 
Restricted cash included in Other noncurrent assets
— 7.9 
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows
$2,011.8 $2,160.2 
Summary of Non-Cash Investing and Financing Activities
September 30,December 31,September 30,December 31,
(In millions)
2024
2023
2023
2022
Accrued capital expenditures$94.0 $75.4 $98.9 $70.8 
Accrued contingent consideration in connection with acquisitions
$88.0 $71.6 $106.5 $135.5